Anonymization vs. Redaction of Clinical Trial Data
January 17, 2025 The vernacular for disclosing pharmaceutical clinical trial results to the public may…
CertaraJanuary 17, 2025
Management of Vulnerable Patients Hospitalized for COVID-19 With Remdesivir: A Retrospective Comparative Effectiveness Study of Mortality in US Hospitals
Background Coronavirus disease 2019 (COVID-19) remains a major public health concern, with continued resurgences of…
CertaraJanuary 16, 2025
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
January 15, 2025 Full-Year 2024 Revenue of $384.4 million, Bookings of $445.3 million Confirms Adjusted…
CertaraJanuary 15, 2025
Phoenix in the Future: Unveiling the Product Roadmap and the New TFL Module [APAC Webinar]
Principal Research Scientist Dr. Kristin Follman is a Principal Research Scientist at Certara, where she…
CertaraJanuary 15, 2025
Achieve Clinical Data Transparency with the 4 Cs of Collaboration
In this blog, we look at how you can enhance clinical data transparency and make…
CertaraJanuary 15, 2025
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region
The integration of MID3 offers a transformative opportunity for the MENA region to advance pharmaceutical…
CertaraJanuary 14, 2025
What 2025 could bring for psychedelic use in healthcare
Explore the evolving landscape of psychedelic medicine, featuring updates from key players and insights on…
CertaraJanuary 13, 2025
